AU2002335854A1 - 2-phenyl benzimidazoles and imidazo-(4,5)-pyridines as cdsi/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer - Google Patents

2-phenyl benzimidazoles and imidazo-(4,5)-pyridines as cdsi/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer

Info

Publication number
AU2002335854A1
AU2002335854A1 AU2002335854A AU2002335854A AU2002335854A1 AU 2002335854 A1 AU2002335854 A1 AU 2002335854A1 AU 2002335854 A AU2002335854 A AU 2002335854A AU 2002335854 A AU2002335854 A AU 2002335854A AU 2002335854 A1 AU2002335854 A1 AU 2002335854A1
Authority
AU
Australia
Prior art keywords
cdsi
chk2
pyridines
imidazo
chemotherapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002335854A
Inventor
Kristen L. Arienti
Frank U. Axe
J. Guy Breitenbucher
Liming Huang
Alice Lee
Kelly J. Mcclure
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Publication of AU2002335854A1 publication Critical patent/AU2002335854A1/en
Abandoned legal-status Critical Current

Links

AU2002335854A 2001-10-19 2002-10-18 2-phenyl benzimidazoles and imidazo-(4,5)-pyridines as cdsi/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer Abandoned AU2002335854A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60/330,304 2001-10-19

Publications (1)

Publication Number Publication Date
AU2002335854A1 true AU2002335854A1 (en) 2003-04-28

Family

ID=

Similar Documents

Publication Publication Date Title
RS50939B (en) 2-phenyl benzimidazoles and imidazo-/4,5/-pyridines as cdsi/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer
PL370029A1 (en) 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer
HK1162948A1 (en) Hemiasterlin derivatives and uses thereof in the treatment of cancer (hemiasterlin)
EP1409547A4 (en) Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer
AU2003254038A1 (en) Glyconjugates comprising carbohydrate epitopes, methods for theirsynthesis, and their use for the treatment or prophylaxis of cancer
WO2004005326A3 (en) Tubulysin conjugates
IL157993A0 (en) Molecular conjugates for use in cancer treatment and methods for the preparation thereof
HK1068551A1 (en) Substituted benzimidazole compounds and their use for the treatment of cancer
NO20042035L (en) Improved use of antitumor compound in cancer therapy
ZA200500908B (en) Ruthenium anticancer complexes
AU2002346644A1 (en) Use of fpt inhibitors and at least two antineoplastic agents in the treatment of cancer
AU2003212634A8 (en) Compounds useful in the treatment of cancer
AU2003303374A8 (en) Treatment of metastatic cancer with the b-subunit of shiga toxin
IL158206A0 (en) Compositions and methods for the prevention and treatment of human prostate cancer
PL368035A1 (en) Compositions and methods for the treatment of cancer
AU2003274963A1 (en) Mda-7 and free radicals in the treatment of cancer
IL160722A0 (en) Aryloxypropylamines as chemosensitizing agents in the treatment of cancer
AU2002335854A1 (en) 2-phenyl benzimidazoles and imidazo-(4,5)-pyridines as cdsi/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer
HUP0200717A2 (en) Radioactive cisplatin in the treatment of cancer
AU2003219664A1 (en) Methods and therapeutic compositions in the treatment of advanced cancer
AU2002366195A1 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer
AU2002214950A1 (en) Determination of the ability of patients to respond to tumour treatment
AU2002254524A1 (en) Use of semenogelin in the diagnosis, prognosis and treatment of cancer
WO2003059355A8 (en) Quinazolinone compounds in combined modalities for improved cancer treatment
IL160412A0 (en) Methods and pharmaceutical compositions for immune deception, particularly in the treatment of cancer